Gold bars to be exempt from tariffs, White House clarifies
Investing.com - Lake Street Capital Markets upgraded Sight Sciences Inc. (NASDAQ:SGHT) from Hold to Buy with a price target of $5.00 on Friday. The stock has shown strong momentum, gaining over 8.5% in the past week and trading at $4.13, according to InvestingPro data.
The upgrade follows Sight Sciences’ second-quarter 2025 financial results, which exceeded expectations for both revenue and earnings per share, leading the company to raise its 2025 revenue guidance. InvestingPro analysis reveals the company maintains a strong financial position with a current ratio of 10.47, indicating robust liquidity, and holds more cash than debt on its balance sheet.
Lake Street cited several factors supporting the upgrade, including stabilization in the company’s Surgical glaucoma business, prudently set guidance, improved gross margins, and potential catalysts from Dry eye contract wins.
The investment firm noted that Sight Sciences shares currently offer "an attractive risk/reward" ratio, trading at approximately 1.7 times the expected 2025 enterprise value to sales.
Sight Sciences specializes in medical devices for ophthalmology, with products targeting glaucoma and dry eye disease treatment.
In other recent news, Sight Sciences Inc. reported its Q2 2025 earnings, exceeding revenue expectations with $19.6 million, surpassing the forecasted $18.18 million. The company also posted a narrower-than-expected loss per share of $0.23, compared to the anticipated loss of $0.26. These results mark a positive earnings surprise for Sight Sciences. Despite the strong financial performance, the company’s stock experienced a decline in after-hours trading, which aligns with broader market trends. There have been no recent reports of mergers or acquisitions involving Sight Sciences. Analyst firms have not issued any new upgrades or downgrades for the company recently. These developments highlight the company’s current financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.